WuXi AppTec stock

603259 · SSE · CNY

¥144.41Change from previous close: −1.29%Absolute change: −¥1.89

Close · November 16, 2026

Price history

+54.02% over the period

1 year: from ¥93.76 (November 17, 2025) to ¥144.41 (November 16, 2026), +54.02%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026¥144.41
October 30, 2026¥142.01
September 30, 2026¥167.34
August 31, 2026¥154.78
July 31, 2026¥128.43
June 30, 2026¥124.51
May 29, 2026¥101.60
April 30, 2026¥109.55
March 31, 2026¥98.10
February 27, 2026¥98.01
January 30, 2026¥95.20
December 31, 2025¥90.64
November 28, 2025¥91.19
November 17, 2025¥93.76

At a glance

  • The company

    Provides contract research, development and manufacturing services for small molecule drugs and biology solutions across discovery, development and clinical stages

  • Latest results

    Quarter to September 30, 2026 · EPS ¥2.74 (estimate ¥2.55)

TickerLandia's take on WuXi AppTec

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low¥87.09
52-wk high¥173.60

−16.81% from the 52-week high

Analysts · 22 analysts

Average target¥202.34+40.11% vs. price

Buy 22 · Hold 0 · Sell 0 · Strong buy

TickerLandia Fingerprint: WuXi AppTec

Compared with similar companies: very high financial strength, very strong momentum, and very high profitability.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

WuXi AppTec is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), WuXi AppTec's P/E today is 23.5, below the median of its last 8 fiscal years (31.3; between 14.7 and 106.9 from 2018 to 2025). WuXi AppTec's P/E (trailing 12 months): 16.3, −56% against the median of a group of 10 similar companies (36.9).

P/E compared with its history

Compared with 10 similar companies

WuXi AppTec's metrics compared with similar companies
MetricWuXi AppTecPosition in the groupBand
P/E (trailing 12 months)16.3Low
Forward P/E14.4Low
Operating margin44.8%High
ROE30.0%High
Debt/equity0.09Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: WuXi AppTec. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥16.64B

Latest quarter · Q3 2026

Net income

¥8.28B

Latest quarter · Q3 2026

Quarterly net margin

49.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
¥444.01B
P/E
16.3
EPS
¥8.95
Volume
27.67M
Daily trading
€848.12M
Dividend yield
0.35%
Last ex-dividend on September 4, 2026

How WuXi AppTec is changing

All results
  • Revenue grew 21.3% a year on average over the last 5 years

  • Operating margin rose from 23.2% to 37.9%

  • Free cash flow equal to 73% of net income

Returns

WuXi AppTec returns with dividends

¥1,000 invested in WuXi AppTec 5 years ago, on November 16, 2021, would be worth ¥1,153 today with dividends reinvested: +15.29% in total, +2.89% per year. On price alone it would be ¥1,058 (+5.81%).

PeriodWuXi AppTec¥1,000 becomes
1 month+0.08%¥1,001
6 months+40.03%¥1,400
Year to date+59.32%¥1,593
1 year+56.93%¥1,569
3 years+80.90%¥1,809
5 years+15.29%¥1,153

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

WuXi AppTec: technical analysis

WuXi AppTec shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 14.0% below its all-time closing high (¥168.00, July 1, 2021).

Trend
No clear trend
RSI (14 sessions)
45
Between 30 and 70
vs 200-session average
+18.36%

Support and resistance

Price areas where WuXi AppTec has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance¥172.40+19.38%2 touches, last on September 22, 2026
  2. Resistance¥149.96+3.84%2 touches, last on September 11, 2026
  3. Last price¥144.41
  4. Support¥135.53−6.15%2 touches, last on October 23, 2026
  5. Support¥130.52−9.61%2 touches, last on November 3, 2026
  6. Support¥114.80−20.51%4 touches, last on July 20, 2026

Volatility and risk

Volatility (60 sessions, annualised)
43.1%
Largest fall in the last year
−19.46%

Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

WuXi AppTec: seasonality

Average monthly price change over 9 years

+1.5%Jan+2.2%Feb−1.7%Mar−1.2%Apr−1.9%May+5.8%Jun+6.5%Jul+5.9%Aug+5.9%Sep−1.8%Oct−4.2%Nov+1.5%Dec

Over the last 9 years, the strongest month for WuXi AppTec has been July: +6.46% on average, positive in 6 years out of 9. The weakest has been November: −4.15% on average, positive in 2 years out of 8.

Show chart data
MonthAverageMedianPositive years
January+1.49%+2.44%6 of 8
February+2.22%+1.73%5 of 8
March−1.68%−1.17%4 of 8
April−1.16%−5.66%3 of 8
May−1.90%−3.66%3 of 8
June+5.79%+9.44%6 of 9
July+6.46%+4.97%6 of 9
August+5.88%+4.10%5 of 9
September+5.87%+8.11%6 of 9
October−1.79%−0.69%4 of 9
November−4.15%−5.49%2 of 8
December+1.55%+1.62%4 of 8

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

WuXi AppTec and its competitors

With revenue of CNY 43.4 billion in the fiscal year ended December 2025, WuXi AppTec Co., Ltd. operates as an investment holding company whose businesses span drug discovery, development and manufacturing. Its contract research, development and manufacturing services cover small molecules, oligonucleotides, peptides and complex conjugates, from discovery through to commercial production, and include biology services that run from target discovery to candidate selection and clinical entry.

Headquarters
Shanghai, China
Employees
33,834
Founded
2000
Chief executive
Ge Li
WuXi AppTec and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
WuXi AppTec603259$66.55B44.8%16.3+40.03%
WuXi XDC Cayman2268$11.19B28.1%56.4+24.45%
Sonic HealthcareSHL$6.67B9.3%16.2+6.67%
IDEXX LaboratoriesIDXX$55.48B32.5%47.0+33.21%
Lonza GroupLONN$55.48B23.5%44.1+43.25%
Agilent TechnologiesA$49.04B24.5%34.3+54.30%

Same industry or related industries, similar size. Compare WuXi AppTec with its competitors · Full profile